Ian Hector Frazer | |
|---|---|
 | |
| Born | 6 January 1953 Glasgow, Scotland |
| Nationality | Australian, British |
| Alma mater | University of Edinburgh (BSc), (M.B.B.S.); Walter and Eliza Hall Institute of Medical Research; University of Melbourne (M.D.) |
| Known for | HPV vaccine creation |
| Awards | Australian of the Year (2006), Prime Minister's Prize for Science (2008), Australian Living Treasure (2012), Companion of the Order of Australia (2012) |
| Scientific career | |
| Fields | Immunology |
| Institutions | Translational Research Institute, University of Queensland |
Ian Hector Frazer AC (born 6 January 1953) is a Scottish-born Australian immunologist, the founding CEO and Director of Research of the Translational Research Institute (Australia).[1] Frazer and Jian Zhou developed and patented the basic technology behind the HPV vaccine against cervical cancer at the University of Queensland. Researchers at the National Cancer Institute, Georgetown University, and University of Rochester also contributed to the further development of the cervical cancer vaccine in parallel.[2][3]
- ^ "TRI Executive". Translational Research Institute. Archived from the original on 9 April 2013. Retrieved 8 January 2013.
- ^ McNeil C (April 2006). "Who invented the VLP cervical cancer vaccines?". Journal of the National Cancer Institute. 98 (7): 433. doi:10.1093/jnci/djj144. PMID 16595773.
- ^ King, Madonna (2013). Ian Frazer: The man who saved a million lives. Brisbane: University of Queensland Press. ISBN 9780702249570.